Case Report: The Alzheimer’s paradox: a clinically stable amnestic syndrome with full biomarker positivity and minimal imaging evidence

We report the case of a 75-year-old patient with a clinically isolated and stable amnestic syndrome over fifteen years, despite a cerebrospinal fluid (CSF) profile strongly consistent with Alzheimer's disease (AD). Serial PET imaging over two years showed only limited amyloid accumulation, no significant tau deposition, no hypometabolism, and no neuroinflammation. This case illustrates a striking dissociation between biomarker positivity and clinical progression, raising important questions about individual resilience and the prognostic value of AD biomarkers in isolation.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2025-08-19
DOI
https://doi.org/10.3389/fmed.2025.1653232
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: The Alzheimer’s paradox: a clinically stable amnestic syndrome with full biomarker positivity and minimal imaging evidence

Anne-Claire Dupont, Johnny Vercouillie, Nicolas Arlicot, Maria-Joao Santiago Ribeiro et al.
Frontiers in Medicine
Alzheimer's disease research and treatments
article

Case Report: The Alzheimer’s paradox: a clinically stable amnestic syndrome with full biomarker positivity and minimal imaging evidence

Anne-Claire Dupont, Johnny Vercouillie, Nicolas Arlicot, Maria-Joao Santiago Ribeiro, Anna‐Chloé Balageas
article en

Abstract

We report the case of a 75-year-old patient with a clinically isolated and stable amnestic syndrome over fifteen years, despite a cerebrospinal fluid (CSF) profile strongly consistent with Alzheimer's disease (AD). Serial PET imaging over two years showed only limited amyloid accumulation, no significant tau deposition, no hypometabolism, and no neuroinflammation. This case illustrates a striking dissociation between biomarker positivity and clinical progression, raising important questions about individual resilience and the prognostic value of AD biomarkers in isolation.

Frontiers in MedicineVol. 12
Université de Tours (FR), Inserm (FR), Centre Hospitalier Universitaire de Tours (FR)
Openalex Percentile: Top 73%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Case Report: The Alzheimer’s paradox: a clinically stable amnestic syndrome with full biomarker positivity and minimal imaging evidence — Anne-Claire Dupont, Johnny Vercouillie, et al. · Frontiers in Medicine (2025) | TGRS Research Map | TGRS